Tuesday, 26 February 2019

Crispr Infuses First Human in Landmark Gene-Editing Study

Crispr Therapeutics and partner Vertex Pharmaceuticals said on Monday morning that the first patient in a trial using CTX001 received the one-time medicine.

from NDTV Gadgets - Latest https://ift.tt/2XjoJ5n

No comments:

Post a Comment

'Trump May Expand H-1B Program'

'Trump has signaled that he has changed his stance on the H1B visa from his first term.' from rediff Top Interviews https://ift.tt...